Peltopepimut-S

N/A

Report date: 2026/02/26 20:00:22

Base Information

Drug NamePeltopepimut-S
Drug Alias NameHuman papilloma virus type 16 E6/E7 synthetic long peptidesPeltopepimut SISA-HPV-01SLP-HPV-01ISA-HPV-SLP +[13] 
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOropharyngeal Squamous Cell Carcinoma (OPSCC)Solid tumoursAnal intraepithelial neoplasia +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[13] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIsa Pharmaceuticals Bv
China Registration ClassN/A

Develop Information

Active CompaniesIsa Pharmaceuticals BvThe University Of Texas MD Anderson Cancer CenterRegeneron Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsOropharyngeal Squamous Cell Carcinoma (OPSCC)Solid tumoursUterine Cervical Neoplasms +[5] 
Inactive IndicationsAnal intraepithelial neoplasiaOropharyngeal NeoplasmsHead and Neck Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A